IONS vs NRC · rev $514.0M vs P/E 46, rev $70.2M
Ionis Pharmaceuticals Inc (IONS) versus National Research Corp (NRC) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
National Research Corp (NRC) is a health information services company listed on NASDAQ.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
Latest reported NRC revenue for 2026-06-30 was $70.2M. Net income was -$61.0K. NRC currently screens at market cap $400.0M and trailing P/E 45.5.
IONS currently screens at market cap $12.28B. NRC currently screens at market cap $400.0M and trailing P/E 45.5.
Not investment advice. Open the IONS and NRC stock pages for the full models.
Not investment advice.